Healthcare -
Biotechnology - NASDAQ - US
$ 1.27
1.6 %
$ 145 M
Market Cap
-0.77
P/E
FATE - CASH & EQUIVALENTS
Cash & Equivalents FATE - Fate Therapeutics, Inc.
41.9 M
LAST VALUE
-44.01%
2 YEAR CAGR
-26.14%
5 YEAR CAGR
-2.52%
10 YEAR CAGR